BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 10810745)

  • 1. Moisture uptake and its influence on pressurized metered-dose inhalers.
    Williams RO; Hu C
    Pharm Dev Technol; 2000; 5(2):153-62. PubMed ID: 10810745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of water on the solubility of two steroid drugs in hydrofluoroalkane (HFA) propellants.
    Williams RO; Hu C
    Drug Dev Ind Pharm; 2001 Jan; 27(1):71-9. PubMed ID: 11247538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humidity affects the morphology of particles emitted from beclomethasone dipropionate pressurized metered dose inhalers.
    Ivey JW; Bhambri P; Church TK; Lewis DA; McDermott MT; Elbayomy S; Finlay WH; Vehring R
    Int J Pharm; 2017 Mar; 520(1-2):207-215. PubMed ID: 28167262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability and aerosolization of pressurized metered dose inhalers containing thymopentin nanoparticles produced using a bottom-up process.
    Tan Y; Yang Z; Pan X; Chen M; Feng M; Wang L; Liu H; Shan Z; Wu C
    Int J Pharm; 2012 May; 427(2):385-92. PubMed ID: 22343132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical transition to non-CFC pressurized metered dose inhalers.
    Cripps A; Riebe M; Schulze M; Woodhouse R
    Respir Med; 2000 Jun; 94 Suppl B():S3-9. PubMed ID: 10919679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of propellant composition on drug delivery from a pressurized metered-dose inhaler.
    Williams RO; Repka M; Liu J
    Drug Dev Ind Pharm; 1998 Aug; 24(8):763-70. PubMed ID: 9876524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From hydrofluoroalkane pressurized metered dose inhalers (pMDIs) and comparability with chlorofluorocarbon pMDIs.
    Kunka R; Andrews S; Pimazzoni M; Callejas S; Ziviani L; Squassante L; Daley-Yates PT
    Respir Med; 2000 Jun; 94 Suppl B():S10-6. PubMed ID: 10919680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodal particle size distributions emitted from HFA-134a solution pressurized metered-dose inhalers.
    Smyth HD; Hickey AJ
    AAPS PharmSciTech; 2003; 4(3):E38. PubMed ID: 14621970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in physical chemistry and dissolution rate of solid particle aerosols from solution pressurised inhalers.
    Buttini F; Miozzi M; Balducci AG; Royall PG; Brambilla G; Colombo P; Bettini R; Forbes B
    Int J Pharm; 2014 Apr; 465(1-2):42-51. PubMed ID: 24491530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The delivery of chlorofluorocarbon-propelled versus hydrofluoroalkane-propelled beclomethasone dipropionate aerosol to the mechanically ventilated patient: a laboratory study.
    Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC; Migounov VA
    Respir Care; 2003 Nov; 48(11):1025-32. PubMed ID: 14585114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deposition and pharmacokinetics of an HFA formulation of triamcinolone acetonide delivered by pressurized metered dose inhaler.
    Hirst PH; Pitcairn GR; Richards JC; Rohatagi S; Gillen MS; Newman SP
    J Aerosol Med; 2001; 14(2):155-65. PubMed ID: 11681648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol.
    Fireman P; Prenner BM; Vincken W; Demedts M; Mol SJ; Cohen RM
    Ann Allergy Asthma Immunol; 2001 May; 86(5):557-65. PubMed ID: 11379808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro investigation of the effect of ambient humidity on regional delivered dose with solution and suspension MDIs.
    Shemirani FM; Hoe S; Lewis D; Church T; Vehring R; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2013 Aug; 26(4):215-22. PubMed ID: 23094687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of polyvinyl alcohol on the in vitro stability and delivery of spray-dried protein particles from surfactant-free HFA 134a-based pressurised metered dose inhalers.
    Liao YH; Brown MB; Jones SA; Nazir T; Martin GP
    Int J Pharm; 2005 Nov; 304(1-2):29-39. PubMed ID: 16181753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reformulation of Stmerin(®) D CFC formulation using HFA propellants.
    Murata S; Izumi T; Ito H
    Pharm Dev Technol; 2013; 18(6):1314-8. PubMed ID: 22519407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isothermal microcalorimetry of pressurized systems I: a rapid method to evaluate pressurized metered dose inhaler formulations.
    D'Sa DJ; Lechuga-Ballesteros D; Chan HK
    Pharm Res; 2014 Oct; 31(10):2716-23. PubMed ID: 24760449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metered-dose inhaler formulations with beclomethasone-17,21-dipropionate using the ozone friendly propellant R 134a.
    Steckel H; Müller BW
    Eur J Pharm Biopharm; 1998 Jul; 46(1):77-83. PubMed ID: 9700025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Balancing ethanol cosolvent concentration with product performance in 134a-based pressurized metered dose inhalers.
    Gupta A; Stein SW; Myrdal PB
    J Aerosol Med; 2003; 16(2):167-74. PubMed ID: 12823910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isothermal calorimetry: a predictive tool to model drug-propellant interactions in pressurized metered dose systems.
    Ooi J; Gaisford S; Boyd BJ; Young PM; Traini D
    Int J Pharm; 2014 Jan; 461(1-2):301-9. PubMed ID: 24325938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chlorofluorocarbon to hydrofluoroalkane transition: the effect on pressurized metered dose inhaler suspension stability.
    Brindley A
    J Allergy Clin Immunol; 1999 Dec; 104(6):S221-6. PubMed ID: 10588978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.